Holen Sie sich die Stockscreener-App
18.32
0.72%
0.1715
Schlusskurs vom Vortag:
$18.15
Offen:
$18.27
24-Stunden-Volumen:
305.07K
Relative Volume:
0.77
Marktkapitalisierung:
$882.07M
Einnahmen:
$151.91M
Nettoeinkommen (Verlust:
$-46.03M
KGV:
-18.14
EPS:
-1.01
Netto-Cashflow:
$5.65M
1W Leistung:
-7.96%
1M Leistung:
-17.77%
6M Leistung:
-28.34%
1J Leistung:
-27.06%
1-Tages-Spanne:
$17.86
$19.56
1-Wochen-Bereich:
$17.86
$20.06
52-Wochen-Spanne:
$17.86
$29.62
Biolife Solutions Inc Stock (BLFS) Company Profile
Firmenname
Biolife Solutions Inc
Sektor
Telefon
(425) 401-1400
Adresse
3303 MONTE VILLA PARKWAY, BOTHELL, WA
Compare BLFS vs ISRG, BDX, ALC, RMD, MDLN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BLFS
Biolife Solutions Inc
|
18.32 | 873.89M | 151.91M | -46.03M | 5.65M | -1.01 |
|
ISRG
Intuitive Surgical Inc
|
470.97 | 170.20B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
159.56 | 45.41B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
76.99 | 38.26B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
RMD
Resmed Inc
|
231.00 | 33.86B | 5.40B | 1.49B | 1.78B | 10.12 |
|
MDLN
Medline Inc
|
41.48 | 33.33B | 28.43B | 1.16B | 1.26B | 1.4457 |
Biolife Solutions Inc Stock (BLFS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-22 | Fortgesetzt | Stephens | Overweight |
| 2024-09-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-04-04 | Eingeleitet | Jefferies | Buy |
| 2023-07-11 | Eingeleitet | Craig Hallum | Buy |
| 2022-04-25 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2021-10-19 | Eingeleitet | B. Riley Securities | Buy |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-05-14 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2021-03-23 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-09-22 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-09-18 | Eingeleitet | Cowen | Outperform |
| 2020-08-11 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2020-07-08 | Bestätigt | Maxim Group | Buy |
| 2020-02-24 | Eingeleitet | Lake Street | Buy |
| 2020-02-19 | Eingeleitet | The Benchmark Company | Buy |
| 2020-02-06 | Fortgesetzt | B. Riley FBR | Buy |
| 2020-01-08 | Eingeleitet | Stephens | Overweight |
| 2019-11-21 | Eingeleitet | Oppenheimer | Outperform |
| 2019-07-22 | Eingeleitet | H.C. Wainwright | Buy |
| 2017-11-10 | Bestätigt | Maxim Group | Buy |
| 2017-09-19 | Bestätigt | Maxim Group | Buy |
| 2017-07-05 | Hochstufung | Janney | Neutral → Buy |
| 2017-03-10 | Bestätigt | Maxim Group | Buy |
| 2017-01-19 | Eingeleitet | Maxim Group | Buy |
Alle ansehen
Biolife Solutions Inc Aktie (BLFS) Neueste Nachrichten
After Plunging 17.6% in 4 Weeks, Here's Why the Trend Might Reverse for BioLife Solutions (BLFS) - Yahoo! Finance Canada
BioLife Solutions (NASDAQ:BLFS) Hits New 1-Year Low on Insider Selling - MarketBeat
Insider Sell: Karen Foster Sells 97,423 Shares of BioLife Soluti - GuruFocus
Karen Foster Sells 96,923 Shares of BioLife Solutions (NASDAQ:BLFS) Stock - MarketBeat
Volatility Watch: What is C4 Therapeutics Incs valuation compared to sector2026 Earnings & Precise Swing Trade Alerts - baoquankhu1.vn
BioLife Solutions Earnings Call Signals Profitable Growth - TipRanks
BioLife Solutions, Inc. $BLFS Shares Purchased by Vanguard Group Inc. - MarketBeat
BioLife Solutions Hits Day High with Strong 7.65% Intraday Surge - Markets Mojo
Cramer Rosenthal Mcglynn LLC Decreases Stock Position in BioLife Solutions, Inc. $BLFS - MarketBeat
BioLife Solutions (NASDAQ:BLFS) EVP Aby Mathew Sells 529 Shares - MarketBeat
Troy Wichterman Sells 588 Shares of BioLife Solutions (NASDAQ:BLFS) Stock - MarketBeat
BLFS SEC FilingsBiolife Solutions Inc 10-K, 10-Q, 8-K Forms - Stock Titan
BioLife Solutions (BLFS) -10%: Stock Drops on ‘Sell the News’ Reaction to Strong Guidance - Trefis
BioLife Solutions (BLFS) -10%: Stock Drops on 'Sell the News' Reaction to Strong Guidance - Trefis
A Look At BioLife Solutions (BLFS) Valuation After Earnings Beat And 2026 Growth Guidance - simplywall.st
BioLife Solutions (NASDAQ:BLFS) Stock Price Down 11.2%Time to Sell? - MarketBeat
BioLife Solutions, Inc. (BLFS) Stock Analysis: 43.87% Potential Upside Captures Investor Attention - DirectorsTalk Interviews
BioLife Solutions, Inc. $BLFS Shares Sold by Royce & Associates LP - MarketBeat
BioLife Solutions Highlights Growth and Strategic Refocus in Presentation - TipRanks
BioLife Solutions issues investor presentation highlighting FY2025 results and 2026 guidance - TradingView
BioLife Solutions (BLFS) details 2025 surge and 2026 profit outlook - Stock Titan
Wall Street Analysts Believe BioLife Solutions (BLFS) Could Rally 35%: Here's is How to Trade - sharewise.com
Does BioLife’s 2026 Profitability Guidance and Media Strength Change The Bull Case For BLFS? - simplywall.st
FY2026 EPS Estimates for BLFS Increased by Analyst - MarketBeat
Should BioLife Solutions’ 2026 Profitability Guidance and Refocus Require Action From BLFS Investors? - Yahoo Finance
BLFS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
BioLife Solutions (NASDAQ:BLFS) Raised to Buy at Wall Street Zen - MarketBeat
BLFS PE Ratio & Valuation, Is BLFS Overvalued - Intellectia AI
BioLife Solutions (NASDAQ:BLFS) Shares Gap UpWhat's Next? - MarketBeat
Can BioLife Solutions Capitalize On The Explosive Growth Of The Cell And Gene Therapy Market? - RTTNews
BioLife Solutions, Inc. (NASDAQ:BLFS) Q4 2025 Earnings Call Transcript - Insider Monkey
BioLife Solutions (BLFS) Q4 Profitability Glimpse Tests Bullish Margin Narratives - Sahm
BioLife Solutions earnings beat by $0.23, revenue topped estimates - Investing.com Canada
Beyond the Balance Sheet: What SWOT Reveals About BioLife Soluti - GuruFocus
BioLife Solutions Inc (BLFS) Q4 2025 Earnings Call Highlights: S - GuruFocus
BioLife Solutions, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Earnings call transcript: BioLife Solutions Q4 2025 earnings beat expectations - Investing.com Nigeria
BioLife Solutions Inc reports results for the quarter ended September 30Earnings Summary - TradingView
BioLife Solutions (BLFS) director receives 8,170-share stock grant - Stock Titan
BioLife Solutions, Inc. (BLFS) Surpasses Q4 Earnings and Revenue Estimates - Yahoo Finance
BioLife Solutions (NASDAQ: BLFS) exec reports stock grant and tax withholding - Stock Titan
BioLife Solutions (NASDAQ: BLFS) CMO gets stock awards and tax withholding - Stock Titan
BioLife Solutions (BLFS) director awarded 8,170 restricted shares - Stock Titan
BioLife Solutions (BLFS) CFO receives 2026 stock grants - Stock Titan
Restricted stock grant to BioLife Solutions (BLFS) director Ellingson - Stock Titan
New stock awards and tax share withholdings for BioLife (BLFS) CEO - Stock Titan
BioLife Solutions (BLFS) EVP granted stock awards and withholds shares for tax - Stock Titan
BioLife Solutions (BLFS) HR chief awarded 23,548 shares - Stock Titan
BioLife Solutions (BLFS) CTO granted 24,116 restricted shares for 2026 pay - Stock Titan
[Form 4] BIOLIFE SOLUTIONS INC Insider Trading Activity - Stock Titan
BioLife Solutions (NASDAQ:BLFS) Posts Quarterly Earnings Results, Beats Estimates By $0.24 EPS - MarketBeat
Finanzdaten der Biolife Solutions Inc-Aktie (BLFS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.05%
0.01%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):